Key facts
| Price (PPV) | 201 MAD |
|---|---|
| Dispensing status | Schedule C — prescription only |
| Composition (DCI) | esoméprazole |
| Class | Drugs for acid-related disorders |
| ATC code | A02BC05 |
| Manufacturer | SUN PHARMACEUTICALS NORTH AFRICA S.A |
| Presentation | Boite de 28 |
| Nature | Médicament |
| Hospital price | 126.20 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'œsophagite de reflux. Prophylaxie à long terme de l'œsophagite de reflux. Traitement symptomatique du reflux gastro-œsophagien (pyrosis, renvois acides) sans œsophagite de reflux érosive/ulcéreuse. Eradication d'Helicobacter pylori en association avec des antibiotiques appropriés Guérison de l'ulcère duodénal associé à une infection par Helicobacter pylori. Prophylaxie des récidives de maladies ulcéreuses associées à Helicobacter pylori. Traitement curatif des ulcères gastriques induits par les AINS (y compris AINS sélectifs de la COX-2). Prévention des ulcères gastriques et duodénaux chez les patients à risque qui prennent des AINS (y compris des AINS sélectifs de la COX-2). Hypersécrétion pathologique y compris syndrome de Zollinger-Ellison et hypersécrétion idiopathique. Prévention de nouvelles hémorragies d'un ulcère gastrique ou duodénal hémorragique après le traitement à l'ésoméprazole i.v.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Raciper 40 mg (SUN PHARMACEUTICALS NORTH AFRICA S.A) contains the same active substance as Raciper 40 mg (Esoméprazole) at the same strength, but in a different pack: Boite de 7 at 65.20 MAD, i.e. 9.31 MAD per unit against 7.18 MAD for Raciper 40 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Raciper 40 mg | SUN PHARMACEUTICALS NORTH AFRICA S.A | Boite de 7 | 65.20 MAD | 9.31 / unit |
| Raciper 40 mg | SUN PHARMACEUTICALS NORTH AFRICA S.A | Boite de 14 | 114.80 MAD | 8.20 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Raciper 40 mg
Raciper 40 mg belongs to the drugs for acid-related disorders therapeutic class. In Morocco, this drug is marketed by SUN PHARMACEUTICALS NORTH AFRICA S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Raciper 40 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Raciper 40 mg
Answers to common questions from Moroccan patients about this drug.